These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34384036)
1. Foretelling Early Lung Disease Progression in Cystic Fibrosis: The Combined Benefits of Magnetic Resonance Imaging and Newborn Screening. Goralski JL Am J Respir Crit Care Med; 2021 Oct; 204(8):880-881. PubMed ID: 34384036 [No Abstract] [Full Text] [Related]
2. Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis. Stahl M; Steinke E; Graeber SY; Joachim C; Seitz C; Kauczor HU; Eichinger M; Hämmerling S; Sommerburg O; Wielpütz MO; Mall MA Am J Respir Crit Care Med; 2021 Oct; 204(8):943-953. PubMed ID: 34283704 [No Abstract] [Full Text] [Related]
3. The remaining barriers to normalcy in CF: Advances in assessment of CF lung disease. Muston HN; Perrem L; Davis MD; Ratjen F; Ren CL Pediatr Pulmonol; 2021 Feb; 56 Suppl 1():S90-S96. PubMed ID: 32589821 [TBL] [Abstract][Full Text] [Related]
4. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Mott LS; Park J; Murray CP; Gangell CL; de Klerk NH; Robinson PJ; Robertson CF; Ranganathan SC; Sly PD; Stick SM; Thorax; 2012 Jun; 67(6):509-16. PubMed ID: 22201161 [TBL] [Abstract][Full Text] [Related]
5. Chest magnetic resonance imaging in cystic fibrosis: technique and clinical benefits. Gräfe D; Prenzel F; Hirsch FW Pediatr Radiol; 2023 Apr; 53(4):640-648. PubMed ID: 36372855 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis. Stahl M; Wielpütz MO; Graeber SY; Joachim C; Sommerburg O; Kauczor HU; Puderbach M; Eichinger M; Mall MA Am J Respir Crit Care Med; 2017 Feb; 195(3):349-359. PubMed ID: 27575911 [TBL] [Abstract][Full Text] [Related]
7. The Swiss Cystic Fibrosis Infant Lung Development (SCILD) cohort. Korten I; Kieninger E; Yammine S; Regamey N; Nyilas S; Ramsey K; Casaulta C; Latzin P; For The Scild Study Group Swiss Med Wkly; 2018; 148():w14618. PubMed ID: 29698544 [TBL] [Abstract][Full Text] [Related]
8. Structural and perfusion magnetic resonance imaging of the lung in cystic fibrosis. Amaxopoulou C; Gnannt R; Higashigaito K; Jung A; Kellenberger CJ Pediatr Radiol; 2018 Feb; 48(2):165-175. PubMed ID: 29143200 [TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis infant care challenges in diagnosis and management in the era of newborn screening. Padman R; Flathers K; Passi V Del Med J; 2012 May; 84(5):149-55. PubMed ID: 22866385 [TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced Magnetic Resonance Imaging Does Not Detect a Progression in Lung Morphological Score in Preschool Children with Cystic Fibrosis. Dournes G; Benlala I; Laurent F Am J Respir Crit Care Med; 2022 Jan; 205(1):134. PubMed ID: 34731588 [No Abstract] [Full Text] [Related]
11. Lung T1 mapping magnetic resonance imaging in the assessment of pulmonary disease in children with cystic fibrosis: a pilot study. Neemuchwala F; Ghadimi Mahani M; Pang Y; Lee E; Johnson TD; Galbán CJ; Fortuna AB; Sanchez-Jacob R; Flask CA; Nasr SZ Pediatr Radiol; 2020 Jun; 50(7):923-934. PubMed ID: 32162080 [TBL] [Abstract][Full Text] [Related]
12. [A critical study of Technetium 99m and Xenon 133 lung scintigraphy in patients with cystic fibrosis]. Loeuille GA; Steinling M; Dubois P; Beuscart R; Farriaux JP Ann Pediatr (Paris); 1983 Feb; 30(2):75-80. PubMed ID: 6830116 [No Abstract] [Full Text] [Related]
13. Risk factors for the progression of cystic fibrosis lung disease throughout childhood. Sanders DB; Li Z; Laxova A; Rock MJ; Levy H; Collins J; Ferec C; Farrell PM Ann Am Thorac Soc; 2014 Jan; 11(1):63-72. PubMed ID: 24261460 [TBL] [Abstract][Full Text] [Related]
16. Reply to Dournes Stahl M; Steinke E; Wielpütz MO; Mall MA Am J Respir Crit Care Med; 2022 Jan; 205(1):134-136. PubMed ID: 34731591 [No Abstract] [Full Text] [Related]
17. Midterm Reproducibility of Chest Magnetic Resonance Imaging in Adults with Clinically Stable Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. Wielpütz MO; Eichinger M; Wege S; Eberhardt R; Mall MA; Kauczor HU; Puderbach MU; Risse F; Heußel CP; Heußel G Am J Respir Crit Care Med; 2019 Jul; 200(1):103-107. PubMed ID: 30875236 [No Abstract] [Full Text] [Related]
18. [Neonatal screening for cystic fibrosis : towards a national implementation in Belgium in 2019]. Boboli H; Boemer F; Mastouri M; Seghaye MC Rev Med Liege; 2018 Oct; 73(10):497-501. PubMed ID: 30335254 [TBL] [Abstract][Full Text] [Related]
19. Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations. Grasemann H; Ciet P; Amin R; McDonald N; Klingel M; Tiddens HAWM; Ratjen F; Grosse-Wortmann L Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28838978 [No Abstract] [Full Text] [Related]
20. Bronchiectasis in an asymptomatic infant with cystic fibrosis diagnosed following newborn screening. Mott LS; Gangell CL; Murray CP; Stick SM; Sly PD; J Cyst Fibros; 2009 Jul; 8(4):285-7. PubMed ID: 19447078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]